These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9627739)

  • 1. Vitamin E, lipids, and lipid peroxidation products in tardive dyskinesia.
    Brown K; Reid A; White T; Henderson T; Hukin S; Johnstone C; Glen A
    Biol Psychiatry; 1998 Jun; 43(12):863-7. PubMed ID: 9627739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Nithsdale Schizophrenia Surveys. XIV: Plasma lipid peroxide and serum vitamin E levels in patients with and without tardive dyskinesia, and in normal subjects.
    McCreadie RG; MacDonald E; Wiles D; Campbell G; Paterson JR
    Br J Psychiatry; 1995 Nov; 167(5):610-7. PubMed ID: 8564316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tardive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin E treatment.
    Peet M; Laugharne J; Rangarajan N; Reynolds GP
    Int Clin Psychopharmacol; 1993; 8(3):151-3. PubMed ID: 8263312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disrupted antioxidant enzyme activity and elevated lipid peroxidation products in schizophrenic patients with tardive dyskinesia.
    Zhang XY; Tan YL; Zhou DF; Cao LY; Wu GY; Haile CN; Kosten TA; Kosten TR
    J Clin Psychiatry; 2007 May; 68(5):754-60. PubMed ID: 17503985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between serum lipid peroxidation products in hypercholesterolemic subjects and vitamin E status.
    Bierenbaum ML; Reichstein RP; Bhagavan HN; Watkins TR
    Biochem Int; 1992 Oct; 28(1):57-66. PubMed ID: 1445395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiobarbituric acid reactive substances in the cerebrospinal fluid in schizophrenia.
    Skinner AO; Mahadik SP; Garver DL
    Schizophr Res; 2005 Jul; 76(1):83-7. PubMed ID: 15927801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA; Mythily ; Lum A; Huak CY; Kane J
    Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid peroxidation in patients with schizophrenia.
    Dietrich-Muszalska A; Kontek B
    Psychiatry Clin Neurosci; 2010 Oct; 64(5):469-75. PubMed ID: 20923426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements.
    Tan YL; Zhou DF; Zhang XY
    Schizophr Res; 2005 May; 74(2-3):263-70. PubMed ID: 15722005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin E treatment of tardive dyskinesia.
    Adler LA; Peselow E; Rotrosen J; Duncan E; Lee M; Rosenthal M; Angrist B
    Am J Psychiatry; 1993 Sep; 150(9):1405-7. PubMed ID: 8102511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased lipid peroxidation in serum and low-density lipoproteins associated with aging in humans.
    Balkan J; Kanbağli O; Mehmetçik G; Mutlu-Türkoğlu U; Aykaç-Toker G; Uysal M
    Int J Vitam Nutr Res; 2002 Oct; 72(5):315-20. PubMed ID: 12463107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of plasma vitamin E, vitamin C, TBARS, and cholesterol in male patients with colorectal tumors.
    Saygili EI; Konukoglu D; Papila C; Akcay T
    Biochemistry (Mosc); 2003 Mar; 68(3):325-8. PubMed ID: 12733974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of tardive dyskinesia with vitamin E.
    Egan MF; Hyde TM; Albers GW; Elkashef A; Alexander RC; Reeve A; Blum A; Saenz RE; Wyatt RJ
    Am J Psychiatry; 1992 Jun; 149(6):773-7. PubMed ID: 1350428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial.
    Lee JG; Shin BS; Lee YC; Park SW; Kim YH
    Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tardive dyskinesia and glucid metabolism.
    Brousse G; Meary A; Mouret J; Blanc O; Hueber T; Lemoine P; Llorca PM; Lachaux B
    Hum Psychopharmacol; 2007 Aug; 22(6):373-80. PubMed ID: 17579925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin E in the treatment of tardive dyskinesia: a meta-analysis.
    Xu H; Qin H; Chen S; Guan M
    Int Clin Psychopharmacol; 2022 Mar; 37(2):60-66. PubMed ID: 35045531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pro- and antioxidant processes in schizophrenics with tardive dyskinesia].
    Gałecki P; Pietras T; Florkowki A
    Psychiatr Pol; 2005; 39(6):1131-41. PubMed ID: 16526180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of vitamin E and cimetidine on peritonitis-induced lipid peroxidation.
    Tuncel P; Gür ES; Kaya E; Ozbek R; Oztürk E; Tokyay R
    Res Exp Med (Berl); 1997; 197(4):235-41. PubMed ID: 9440141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin E, lipid profile, and peroxidation in hemodialysis patients.
    Galli F; Varga Z; Balla J; Ferraro B; Canestrari F; Floridi A; Kakuk G; Buoncristiani U
    Kidney Int Suppl; 2001 Feb; 78():S148-54. PubMed ID: 11169001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus.
    Griesmacher A; Kindhauser M; Andert SE; Schreiner W; Toma C; Knoebl P; Pietschmann P; Prager R; Schnack C; Schernthaner G
    Am J Med; 1995 May; 98(5):469-75. PubMed ID: 7733126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.